Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.59 USD
Change Today -0.27 / -3.94%
Volume 128.6K
As of 4:30 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2275 Research Boulevard

Suite 500

Rockville, MD 20850

United States

Phone: 301-840-3888


Synutra International, Inc. operates as an infant formula company in the People’s Republic of China (China or PRC). The company is principally engaged in the production, distribution, and sale of dairy based nutritional products under the ‘Shengyuan’ or ‘Synutra’ line of brands in the PRC. The company focuses on selling powdered formula products for infant and adults, and is also engaged in other nutritional product offerings, such as prepared foods and certain nutritional ingredients and supplements. The company sells majority of its products through a nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. Segments The company operates through four segments: Powdered Formula, Foods, Nutritional Ingredients and Supplements, and Other Business. Powdered Formula segment This segment covers the sale of powdered infant and adult formula products. Major brands include Super, U-Smart, My Angel, and Dutch Cow. Products Infant Formula The company’s infant formula products include formulas for regular feeding and specialty formula products. The following illustrates the company’s major infant formula brands and products: Regular Infant Formula The company designs regular infant formula as a breast milk substitute for healthy, full-term infants without special nutritional needs, both for use as the infant’s sole source of nutrition and as a supplement to breastfeeding. The company’s regular infant formula has four major components, such as protein from cow’s milk that is processed to have an amino acid profile similar to human milk; a blend of vegetable fats (including docosahexanoic acid (DHA)/arachidonic acid (ARA)) to replace bovine milk fat to resemble the composition of human milk; a carbohydrate, generally lactose from cow’s milk; and a vitamin and mineral ‘micronutrient’ pre-mix that is blended into the product to meet the specific needs of the infant at a given age. Specialty Infant Formula This includes Lactose Free, Formulas for Preterm and Low Birth Weight Infants, Formulas addressing Calcium, Iron or Zinc Deficiency, Formulas of Partially Hydrolyzed Whey Protein, and Subscription only Medical Grade Formulas addressing digestive or metabolic disorder. The company obtained the license to produce specialty infant formulas in five categories from Shandong Bureau of Quality and Technical Supervision. Special infant formulas are designed for infants with special conditions who cannot consume regular infant formulas. The company markets these products under the Super Formula brand name. Lactose free formulas are designed for infants that are lactose intolerant. Lactose is substituted by maltodextrin in this formula, and it is primarily for infants with diarrhea. Formulas for preterm and low birth weight infants are designed to meet these infants’ needs. Typically, such infants need extra assistance obtaining the requisite nutrition. They require a higher density of nutrients and calories because they cannot take in enough volume of breast milk or regular infant formula. The company has formula for infants both when they are under intensive care in the hospital, and after they are discharged from the hospital. The company designed formulas addressing calcium, iron or zinc deficiency for infants with special needs from stage 1 to stage 3. Formulas of partially hydrolyzed whey protein are designed for use by infants that are allergic to the protein in cow’s milk. The company introduced this product to the market in 2013. The company produces medical grade formula, or formulas for special medical purposes, for nutritional management of infants who are born with rare digestive or metabolism disorders. Children’s Formula (Stage 3 and Stage 4) The company markets children’s formula products under the Synutra family of brands. Super, U-Smart, My Angel, Dutch Cow and Super brand formulas addressing Calcium, Iron or Zinc Deficiency are produced for stage 3 and 4. The company designs these products to meet the changing nutrition needs of children at different stages of development. It offers products at stages 3 and 4 that


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYUT:US $6.59 USD -0.27

SYUT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.85 USD -0.15
Biostime International Holdings Ltd $34.90 HKD -0.25
Danone SA €63.68 EUR -1.29
Inner Mongolia Yili Industrial Group Co Ltd CNY35.68 CNY -1.20
Mead Johnson Nutrition Co $97.05 USD +0.31
View Industry Companies

Industry Analysis


Industry Average

Valuation SYUT Industry Range
Price/Earnings 7.1x
Price/Sales 1.0x
Price/Book 4.1x
Price/Cash Flow 7.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNUTRA INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at